細胞表面マーカーの世界市場2024~2028

■ 英語タイトル:Global Cell Surface Markers Market 2024-2028

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR71681-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR71681-23
■ 発行日:2023年10月11日
■ 調査対象地域:北米、ヨーロッパ、アジア、その他地域
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[細胞表面マーカーの世界市場2024~2028]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

細胞表面マーカーの世界市場 2024-2028細胞表面マーカー市場は、2023年から2028年にかけて1億4,068億5,000万米ドルの成長が予測され、予測期間中のCAGRは8.25%で加速すると予測されています。この調査レポートは、細胞表面マーカー市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。COVID-19のパンデミックによる影響、精密医療への需要の高まり、診断薬の使用の増加などが市場を牽引しています。

Technavio社の細胞表面マーカー市場は以下のように分類されます。
用途別
- 疾患診断
- 研究
- 創薬

製品別
- 抗体
- PCRアレイ

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間における細胞表面マーカー市場の成長を促進する主な理由の1つとして、癌検出における診断用途の増加を挙げています。また、フローサイトメトリー技術の人気の高まりと人工知能と機械学習の統合は、市場での大規模な需要につながるでしょう。

細胞表面マーカー市場に関するレポートは以下の分野をカバーしています。
- 細胞表面マーカー市場規模
- 細胞表面マーカー市場の予測
- 細胞表面マーカー市場の産業分析

本レポートでは、細胞表面マーカー市場の主要ベンダーとして、Abbott Laboratories、Abcam plc、Agilent Technologies Inc.、Becton Dickinson and Co.、Bio Rad Laboratories Inc、 Bio Techne Corp.、Cell Signaling Technology Inc.、Danaher Corp.、DiaSorin SpA、F. Hoffmann La Roche Ltd.、GenScript Biotech Corp.、Grifols SA、IVD Medical Holding Ltd.、Johnson and Johnson、PerkinElmer Inc.、QIAGEN NV、Siemens Healthineers AG、Sysmex Corp.、Thermo Fisher Scientific Inc.、Werfenlife SAなどを分析しています。また、細胞表面マーカー市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 細胞表面マーカーの世界市場:用途別市場分析
7 細胞表面マーカーの世界市場:製品別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global cell surface markers market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global cell surface markers market 2018 – 2022 ($ million)
o 4.2 Application Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Application Segment 2018 – 2022 ($ million)
o 4.3 Product Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application – Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Disease diagnosis – Market size and forecast 2023-2028
o Exhibit 34: Chart on Disease diagnosis – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Disease diagnosis – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Disease diagnosis – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Disease diagnosis – Year-over-year growth 2023-2028 (%)
o 6.4 Research and drug discovery – Market size and forecast 2023-2028
o Exhibit 38: Chart on Research and drug discovery – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Research and drug discovery – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Research and drug discovery – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Research and drug discovery – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Application
o Exhibit 42: Market opportunity by Application ($ million)
o Exhibit 43: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product – Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Antibody – Market size and forecast 2023-2028
o Exhibit 48: Chart on Antibody – Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Antibody – Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Antibody – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Antibody – Year-over-year growth 2023-2028 (%)
o 7.4 PCR array – Market size and forecast 2023-2028
o Exhibit 52: Chart on PCR array – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on PCR array – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on PCR array – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on PCR array – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 56: Market opportunity by Product ($ million)
o Exhibit 57: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 China – Market size and forecast 2023-2028
o Exhibit 83: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 France – Market size and forecast 2023-2028
o Exhibit 91: Chart on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on France – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.11 UK – Market size and forecast 2023-2028
o Exhibit 95: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 Abcam plc
o Exhibit 112: Abcam plc – Overview
o Exhibit 113: Abcam plc – Product / Service
o Exhibit 114: Abcam plc – Key news
o Exhibit 115: Abcam plc – Key offerings
o 12.5 Agilent Technologies Inc.
o Exhibit 116: Agilent Technologies Inc. – Overview
o Exhibit 117: Agilent Technologies Inc. – Business segments
o Exhibit 118: Agilent Technologies Inc. – Key offerings
o Exhibit 119: Agilent Technologies Inc. – Segment focus
o 12.6 Becton Dickinson and Co.
o Exhibit 120: Becton Dickinson and Co. – Overview
o Exhibit 121: Becton Dickinson and Co. – Business segments
o Exhibit 122: Becton Dickinson and Co. – Key news
o Exhibit 123: Becton Dickinson and Co. – Key offerings
o Exhibit 124: Becton Dickinson and Co. – Segment focus
o 12.7 Bio Rad Laboratories Inc.
o Exhibit 125: Bio Rad Laboratories Inc. – Overview
o Exhibit 126: Bio Rad Laboratories Inc. – Business segments
o Exhibit 127: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 128: Bio Rad Laboratories Inc. – Segment focus
o 12.8 Danaher Corp.
o Exhibit 129: Danaher Corp. – Overview
o Exhibit 130: Danaher Corp. – Business segments
o Exhibit 131: Danaher Corp. – Key news
o Exhibit 132: Danaher Corp. – Key offerings
o Exhibit 133: Danaher Corp. – Segment focus
o 12.9 DiaSorin SpA
o Exhibit 134: DiaSorin SpA – Overview
o Exhibit 135: DiaSorin SpA – Business segments
o Exhibit 136: DiaSorin SpA – Key news
o Exhibit 137: DiaSorin SpA – Key offerings
o Exhibit 138: DiaSorin SpA – Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 139: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 140: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 142: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 143: F. Hoffmann La Roche Ltd. – Segment focus
o 12.11 Grifols SA
o Exhibit 144: Grifols SA – Overview
o Exhibit 145: Grifols SA – Business segments
o Exhibit 146: Grifols SA – Key offerings
o Exhibit 147: Grifols SA – Segment focus
o 12.12 Johnson and Johnson
o Exhibit 148: Johnson and Johnson – Overview
o Exhibit 149: Johnson and Johnson – Business segments
o Exhibit 150: Johnson and Johnson – Key news
o Exhibit 151: Johnson and Johnson – Key offerings
o Exhibit 152: Johnson and Johnson – Segment focus
o 12.13 PerkinElmer Inc.
o Exhibit 153: PerkinElmer Inc. – Overview
o Exhibit 154: PerkinElmer Inc. – Business segments
o Exhibit 155: PerkinElmer Inc. – Key news
o Exhibit 156: PerkinElmer Inc. – Key offerings
o Exhibit 157: PerkinElmer Inc. – Segment focus
o 12.14 QIAGEN NV
o Exhibit 158: QIAGEN NV – Overview
o Exhibit 159: QIAGEN NV – Product / Service
o Exhibit 160: QIAGEN NV – Key news
o Exhibit 161: QIAGEN NV – Key offerings
o 12.15 Sysmex Corp.
o Exhibit 162: Sysmex Corp. – Overview
o Exhibit 163: Sysmex Corp. – Business segments
o Exhibit 164: Sysmex Corp. – Key offerings
o Exhibit 165: Sysmex Corp. – Segment focus
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 166: Thermo Fisher Scientific Inc. – Overview
o Exhibit 167: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 168: Thermo Fisher Scientific Inc. – Key news
o Exhibit 169: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 170: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Werfenlife SA
o Exhibit 171: Werfenlife SA – Overview
o Exhibit 172: Werfenlife SA – Product / Service
o Exhibit 173: Werfenlife SA – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global cell surface markers market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Application Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Product Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Application – Market share 2023-2028 (%)
Exhibits31: Data Table on Application – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Disease diagnosis – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Disease diagnosis – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Disease diagnosis – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Disease diagnosis – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Research and drug discovery – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Research and drug discovery – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Research and drug discovery – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Research and drug discovery – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Product – Market share 2023-2028 (%)
Exhibits45: Data Table on Product – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Antibody – Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Antibody – Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Antibody – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Antibody – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on PCR array – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on PCR array – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on PCR array – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on PCR array – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ million)
Exhibits57: Data Table on Market opportunity by Product ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on France – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on France – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: Abcam plc – Overview
Exhibits113: Abcam plc – Product / Service
Exhibits114: Abcam plc – Key news
Exhibits115: Abcam plc – Key offerings
Exhibits116: Agilent Technologies Inc. – Overview
Exhibits117: Agilent Technologies Inc. – Business segments
Exhibits118: Agilent Technologies Inc. – Key offerings
Exhibits119: Agilent Technologies Inc. – Segment focus
Exhibits120: Becton Dickinson and Co. – Overview
Exhibits121: Becton Dickinson and Co. – Business segments
Exhibits122: Becton Dickinson and Co. – Key news
Exhibits123: Becton Dickinson and Co. – Key offerings
Exhibits124: Becton Dickinson and Co. – Segment focus
Exhibits125: Bio Rad Laboratories Inc. – Overview
Exhibits126: Bio Rad Laboratories Inc. – Business segments
Exhibits127: Bio Rad Laboratories Inc. – Key offerings
Exhibits128: Bio Rad Laboratories Inc. – Segment focus
Exhibits129: Danaher Corp. – Overview
Exhibits130: Danaher Corp. – Business segments
Exhibits131: Danaher Corp. – Key news
Exhibits132: Danaher Corp. – Key offerings
Exhibits133: Danaher Corp. – Segment focus
Exhibits134: DiaSorin SpA – Overview
Exhibits135: DiaSorin SpA – Business segments
Exhibits136: DiaSorin SpA – Key news
Exhibits137: DiaSorin SpA – Key offerings
Exhibits138: DiaSorin SpA – Segment focus
Exhibits139: F. Hoffmann La Roche Ltd. – Overview
Exhibits140: F. Hoffmann La Roche Ltd. – Business segments
Exhibits141: F. Hoffmann La Roche Ltd. – Key news
Exhibits142: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits144: Grifols SA – Overview
Exhibits145: Grifols SA – Business segments
Exhibits146: Grifols SA – Key offerings
Exhibits147: Grifols SA – Segment focus
Exhibits148: Johnson and Johnson – Overview
Exhibits149: Johnson and Johnson – Business segments
Exhibits150: Johnson and Johnson – Key news
Exhibits151: Johnson and Johnson – Key offerings
Exhibits152: Johnson and Johnson – Segment focus
Exhibits153: PerkinElmer Inc. – Overview
Exhibits154: PerkinElmer Inc. – Business segments
Exhibits155: PerkinElmer Inc. – Key news
Exhibits156: PerkinElmer Inc. – Key offerings
Exhibits157: PerkinElmer Inc. – Segment focus
Exhibits158: QIAGEN NV – Overview
Exhibits159: QIAGEN NV – Product / Service
Exhibits160: QIAGEN NV – Key news
Exhibits161: QIAGEN NV – Key offerings
Exhibits162: Sysmex Corp. – Overview
Exhibits163: Sysmex Corp. – Business segments
Exhibits164: Sysmex Corp. – Key offerings
Exhibits165: Sysmex Corp. – Segment focus
Exhibits166: Thermo Fisher Scientific Inc. – Overview
Exhibits167: Thermo Fisher Scientific Inc. – Business segments
Exhibits168: Thermo Fisher Scientific Inc. – Key news
Exhibits169: Thermo Fisher Scientific Inc. – Key offerings
Exhibits170: Thermo Fisher Scientific Inc. – Segment focus
Exhibits171: Werfenlife SA – Overview
Exhibits172: Werfenlife SA – Product / Service
Exhibits173: Werfenlife SA – Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR71681-23 )"細胞表面マーカーの世界市場2024~2028" (英文:Global Cell Surface Markers Market 2024-2028)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。